NASDAQ:ONCT Oncternal Therapeutics Inc
Target PT 11 and higher
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like...
This small-cap is a long-time leader in the oncology industry and has been highly rated by analysts in recent weeks.
Oncternal Therapeutics, Inc. (ONCT) Q4 2020 Earnings Call Transcript: www.fool.com
Interesting analysis: stocksregister.com
beautiful play to swing trade if you enter on bottom trendline dip! has been rejected off top trendline resistance 4 times in previous months so be cautious when entering here! of course resistance will turn into support if 10 breaks so be on the lookout for a bigger breakout!
Bullish Pennant (50%)
Pros:
Volume during post formation
Descending volume during triangle formation
PPS above 50MA and 200MA
RS above 0 and ascending
ATR Ascending
R/R ratio above 5
250RSI above 50 and ascending
200MA ascending
Target:
PT = 20.10$
Help how ever you can to keep this alive.
Thank you to those who have donated Coins!
Always do your own due...
The RSI has yet to break its overbought threshold, it never fell back into the gap, it closed above the Bollinger Bands upper and the upper intersects a bullish trend line. I'm betting on this one to run LONG into that resistance line.
we have made a good amount of money off this ticker in the past, and i didnt even know ark was in when we got it the first time.. looking to enter over 5.2 with stop loss at 4. price target after entry would be 8-10. great risk reward here. goodluck to longs :)
ONCT has reached a crucial level on the eve of earnings news.
It might crash down if it can't hold above this level or it might climb to $8.2 if it can hold above this level.
Earnings call on Thursday will fuel the move up or down.
Position will be based on the next couple days.
